Stock CURE PHAR
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News CURE PHAR Other OTC

Equities

US56088C1009

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for CURE PHAR

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Leading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing Market
GL
CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids
GL
CURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.
GL
CURE Pharmaceutical Announces Crosslink Patent for Covering Company’s Proprietary CureFilm™ Drug Delivery Technology
GL
CURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis Industry
GL
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
GL
CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors
GL
CURE Pharmaceutical Announces Development and Licensing Deal with Redbarn Pet Products
GL
CURE Pharmaceutical To Exhibit at the 8th Global Drug Delivery & Formulation Summit
GL
CURE Pharmaceutical Welcomes Researcher and Innovator in Pediatric Medicine Michael Neely to Advisory Board
GL
CURE Pharmaceutical Announces Product Development and Licensing Deal with Diverse International Pharmaceutical Company Meroven, Ltd.
GL
CURE Pharmaceutical To Exhibit at INTERPHEX 2017 in New York City
GL
Industry Veteran Jessica Rousset Joins CURE Pharmaceutical As Chief Business Officer
GL
CURE Pharmaceutical Announces US Patent Allowances for Its Oral Thin Film Technology For Manufacture and Use in Pet Products
GL
CURE Pharmaceutical Announces Research Collaboration with CannaKids to Develop Cannabinoid and Terpene Molecules Using Cure’s Proprietary Delivery Technologies
GL
CURE Pharmaceutical Welcomes Industry Veteran Richard Serbin to its Advisory Board
GL
CURE Pharmaceutical Moves to OTCQB Exchange
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. News CURE PHAR